Searched for
GLENMARK PHARMACEUTICALS STOCK PERFORMANCE
Glenmark Pharma Q2 Results: Net profit plunges 56% to Rs 264 crore, revenue down at Rs 4,247 crGlenmark Pharmaceuticals experienced a 56.78 percent drop in consolidated profit after tax during the September quarter. Total revenue from...- Pills are paying off! Pharma stocks lead 2026 rally with up to 112% returnIn 2026, India's pharmaceutical stocks are making headlines with impressive year-to-date gains. This surge is driven by strong domestic dem...
- Stocks in news: BSE, Lenskart, Nykaa, Bharti Airtel, LIC, Aurobindo Pharma and NalcoIndian equity markets have enjoyed a remarkable stretch, registering gains for five consecutive sessions. The Nifty 50 index showed impress...
- 12 BSE 500 stocks defy market trend, rally up to 65% in 3 monthsWhile the BSE 500 declined around 5% over the past three months, 12 stocks bucked the broader market trend, delivering gains ranging from 2...
- Apple drops with most of Wall Street, but gains for other Big Tech stocks cushion the blowThe stock market has been shaky recently as technology and artificial-intelligence stocks have swung on worries their prices shot too high ...
- Why is the US stock market split as Americans vote in the 2026 midterm elections today? Dow falls as S&P 500 and Nasdaq rise; Apple, Nvidia, and AMD in focus - gold and silver dipUS stock market today: US stocks opened mixed on Tuesday as Americans voted in the midterm elections. Investors are also waiting for AMD’s ...
- European shares fall as tech stocks slide, Middle East tensions weighEuropean shares declined as technology stocks led losses amid concerns over AI valuations and escalating US-Iran tensions. Rising oil price...
- Emcure Pharma shares jump 7% after Q2 profit rises 29% YoY to Rs 325 croreEmcure Pharmaceuticals shares rose up to 7.3% after the company reported a 29.3% year-on-year increase in Q2 FY27 profit to Rs 325.1 crore....
- Bayer raises 2026 profit outlook on strong pharmaceuticals performanceBayer raised its 2026 profit outlook after its pharmaceuticals division delivered stronger-than-expected third-quarter sales. The German gr...
- Stocks in news: ITC, Marico, SBI, Yatra Online, NSE, Container Corp and Sun PharmaIndian equity benchmarks experienced gains, with Nifty nearing the 23,500 resistance level and strong corporate earnings reported. ITC face...
- Stocks rose after every US midterm elections since 1946. Why that streak may not mean what investors thinkTomorrow Americans vote in the midterms, and a lot of investors are asking one thing; will stocks go up afterward? History says yes. The S&...
- Mold-Tek Packaging shares surge 17% as Q2 FY 27 profit jumps 35% YoY to Rs 21 croreMold-Tek Packaging shares surged nearly 17% after the company reported a 35.5% YoY rise in Q2 FY27 net profit and 30.5% revenue growth. Str...
- Sun Pharma’s specialty portfolio, Organon deal to drive growthSun Pharmaceutical achieved notable revenue growth in the September quarter, driven by strong performance in India and specialty medicines....
- Nifty 50 vs S&P 500 vs Brazil Bovespa vs Japan Nikkei: Which share market performed the best in last 10 yearsWelcome to TrendMap, your quick guide to investment performance. This edition tracks 10 years of global equity returns. Currency fluctuatio...
- Short-term headwinds, yes; owning the ecosystem is better: 20 healthcare stocks with downside risk of 23% to upside potential of 41%The healthcare sector is under scrutiny. The issue is pricing: What medicines cost and on what hospitals and the rest of the health ecosyst...
- ET Wealth Expo: In uncertain markets, investors can control only consistency and quality of their inputs, says Swarup Mohanty, Mirae Asset MFSwarup Mohanty of Mirae Asset urged investors to focus on the consistency and quality of their investment decisions rather than market move...
- Laurus Labs shares climb 4% after Q2 profit zooms 126% YoYLaurus Labs shares rose 3.79% to Rs 2,329 after the pharmaceutical company reported strong Q2FY27 results. Revenue increased 33% year-on-ye...
- Nifty rout hides a striking bull run: Smallcap universe gives 60 multibaggers since last DiwaliThe stock market in India has encountered a rough patch, evidenced by the Nifty's decline of over 11% since last Diwali. However, smallcap ...
- Cipla’s US recovery, biosimilar pipeline key to future growth prospectsCipla's September-quarter earnings suffered due to a high base in its US business. The company reported sequential growth driven by its str...
- Cipla Q2 Results: Profit falls 35% YoY to Rs 878 crore; revenue slips 2%Cipla reported a 35% drop in consolidated net profit for Q2FY27, which stood at Rs 878 crore. The company also experienced a 2.4% year-on-y...
Load More
